Camelot Portfolios, LLC Gsk PLC Transaction History

Camelot Portfolios, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 25, 2019	SELL	$38.57 - $42.69 $722,261 - $799,412	-18,726 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$37.8 - $42.69 $8,920 - $10,074	236 Added 1.28%	18,726 $716,000
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $11,567 - $12,422	-291 Reduced 1.55%	18,490 $743,000
Q2 2018 Aug 13, 2018	BUY	$39.61 - $42.76 $423,351 - $457,018	10,688 Added 132.06%	18,781 $757,000
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $459,413 - $509,824	-12,698 Reduced 61.07%	8,093 $801,000
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $10,248 - $12,151	-290 Reduced 1.38%	20,791 $737,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $831,434 - $875,915	21,081	21,081 $856,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.